S&P moves U.S. Acute Care view to stable

S&P said it revised its outlook for U.S. Acute Care Solutions Inc. to stable from positive and affirmed all its ratings, including the B- issuer rating.

“The outlook revision reflects our expectation that Usacs will generate modest free cash flow (after incorporating both cash and PIK payments on the preferred debt) in 2023 and 2024 while maintaining an S&P Global Ratings-adjusted margin in the 9%-11% range.

“We expect the company will increase its organic revenue by the low-single digit percent area in 2023 despite lower acuity levels following the coronavirus pandemic, the long-term trend of declining emergency room volumes due to the growing use of technology, the availability of more alternate sites of care for patients (such as urgent care and ambulatory surgical centers), and proactive utilization management efforts by both public and private payors,” S&P said in a statement.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.